Abbott Laboratories (ABT) Stock Falls 8% After Missing Q4 Revenue Target

TLDR Abbott Laboratories stock dropped 8% Thursday after reporting Q4 revenue of $11.5 billion, missing the $11.8 billion consensus Nutrition sales collapsed 8.9% as higher prices reduced consumer demand while commodity costs remained elevated Medical devices surged 12% and pharmaceuticals grew 9%, but diagnostics fell 2.5% on lower COVID testing Company forecasts 2026 adjusted earnings [...]

The post Abbott Laboratories (ABT) Stock Falls 8% After Missing Q4 Revenue Target appeared first on Blockonomi.